Thoratec scored the FDA's blessing to market a next-generation controller for the HeartMate II implant, giving the company a user-friendly face for its market-leading left ventricular assist device.
GE Healthcare is unveiling new magnetic resonance imaging technique that--perhaps unintentionally--addresses an unfortunate market need created by health concerns over all-metal hip implants. In short, it helps detect implant-related problems before they become too serious.
St Jude Medical has won European clearance for the Ilumien Optis PCI Optimization System, technology designed to help treat coronary artery disease by modeling vessels and guiding stent placement.
Hip implants have drawn a lot of negative attention in recent years, largely because of all the safety problems that have erupted--and continue to erupt--for all-metal models. But the truth is that the sector as a whole remains a reliable bread-and-butter source of revenue for the major manufacturers. Read more >>
Hip and knee implant makers, take note: Researchers have come up with a blood diagnostic test that detects allergies to nickel, a metal commonly used in those products.
While Abbott Laboratories leads the way in the dissolvable stent market, California's Elixir Medical is right on its heels, winning CE mark approval for the DESolve device.
Edwards Lifesciences has watched its share price tank about 19% since late last month, and now the company is plotting a $750 million stock buyback to reaffirm investor confidence, with CEO Michael Mussallem pitching in $5 million of his own.
Colorado's Lanx has wrapped up a $15 million Series C, money the devicemaker will use to market its spinal fusion technologies around the globe.
St. Jude Medical's much-scrutinized defibrillator leads remained almost 100% safe from abrasion and mechanical failure after 5 years, according to an independent analysis, results the company hopes will quiet alarm from regulators and competitors.
A top U.K. health regulator's report last year concluding Poly Implant Prosthese's (PIP) substandard breast implants didn't pose long-term health risks to women who had them likely caused some to breathe a sigh of relief. But two leading scientists are now questioning the finding.